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11 P-Hydroxysteroid Dehydrogenase in Cultured Hippocampal 
Cells Reactivates Inert 11 -Dehydrocorticosterone, 
Potentiating Neurotoxicity 
Vidya Rajan, Christopher R. W. Edwards, and Jonathan R. Seckl 
Edinburgh University, Department of Medicine, Western Genera/ Hospital, Edinburgh EH4 2XU, United Kingdom 
11 P-Hydroxysteroid dehydrogenase (1 1 /3-HSD) catalyzes the 
conversion of the glucocorticoid cotticosterone (cortisol in hu- 
mans) to inert 11 -dehydrocot-ticosterone (cortisone). 11 P-HSD 
activity is present in the hippocampus, where it is induced by 
glucocot-ticoids and stress in vivo, prompting suggestions that 
the enzyme may attenuate the deleterious effects of chronic 
glucocorticoid excess on neuronal function and survival. Two 
isoforms exist: 11 P-HSDI , a bidirectional NADPH-dependent 
enzyme, and 11 P-HSD2, an NAD+-dependent exclusive 11 p- 
dehydrogenase (corticosterone-inactivating enzyme). In this 
study, 1 l/l-HSDl activity and mRNA synthesis were demon- 
strated in primary fetal hippocampal cell cultures. Unexpect- 
edly, the reaction direction in intact hippocampal cells was 
11 p-reduction (reactivation of inert 11 -dehydrocotticosterone), 
although homogenization revealed that the enzyme was capa- 
ble of 1 lp-dehydrogenation when removed from its normal 
cellular context. Dexamethasone (1 Op7 M) increased 11 P-HSD 
activity in homogenates of hippocampal cultures (102% in- 
crease). In intact hippocampal cells, dexamethasone in- 
duced 11 preductase, not dehydrogenase. To determine the 
functional relevance of hippocampal 11 p-reductase, glu- 
cocorticoid potentiation of kainic acid neurotoxicity was ex- 
amined. Pretreatment of hippocampal cells with cot-ticosterone 
reduced survival on kainate exposure. Hippocampal cell 11 p- 
HSD activity was potently inhibited by carbenoxolone. Carben- 
oxolone had no effect on cell survival after kainate alone and did 
not alter the effect of corticosterone. 11 -Dehydrocotticosterone 
also potentiated kainate neurotoxicity; this effect was lost, how- 
ever, if 11 P-HSD was inhibited with carbenoxolone. Thus, hip- 
pocampal 11 fi-HSD seems to be a functional 11 P-reductase in 
intact cells. Measures to attenuate hippocampal 11 p-reductase 
may reduce neuronal vulnerability to glucocorticoid toxicity. 
Key words: NADPH; dexamethasone; glucocorticoids; car- 
benoxolone; corticosterone; kainic acid 
11/3-Hydroxysteroid dehydrogenase (1 l@HSD) catalyzes the con- 
version of physiological glucocorticoids (corticosterone, cortisol) 
to inert 11-keto derivatives (11-dehydrocorticosterone, cortisone) 
(Monder and White, 1993). In viva, llS-HSD ensures selective 
access of aldosterone over corticosterone to mineralocorticoid 
receptors (MRs) in the distal nephron (Edwards et al., 1988; 
Funder et al., 1988); MRs are otherwise nonselective and bind 
corticosterone with similar affinity to aldosterone in vitro (Arriza 
et al., 1987, 1988). When 11/3-HSD is congenitally absent or 
inhibited by licorice (or its derivative carbenoxolone), glucocorti- 
coids illicitly occupy renal MRs, causing sodium retention and 
hypertension (Stewart et al., 1987, 1988, 1990). 
Glucocorticoids, which are released from the adrenal cortex in 
response to circadian or stress-induced activation of the hypo- 
thalamic-pituitary-adrenal axis, subserve many roles in ho- 
meostasis and the response to stress. The brain is a key target for 
glucocorticoid action, which is mediated via both MRs and lower 
affinity glucocorticoid receptors (McEwen et al., 1986a; de Kloet, 
1991; Seckl and Olsson, 1995). The hippocampus expresses a 
higher density of MRs than does the kidney, but these sites are 
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occupied by corticosterone in vivo (de Kloet et al., 1975; Reul and 
de Kloet, 1985; McEwen et al., 1986a; de Kloet, 1991), suggesting 
that llP-HSD is absent. However, several recent studies have 
demonstrated llP-HSD activity, immunoreactivity, and mRNA 
expression in hippocampal cells (neurons) (Moisan et al., 1990; 
Lakshmi et al., 1991; Sakai et al., 1992), raising the possibility of 
an aldosterone-selective subset of hippocampal MRs (Moisan et 
al., 1990). Indeed, some data suggest that a proportion of hip- 
pocampal aldosterone binding is not readily displaced by cortico- 
sterone (McEwen et al., 1986b) and that not all functions of 
aldosterone and corticosterone in the hippocampus are identical 
(de Kloet et al., 1983). Administration of llP-HSD inhibitors 
alters functional activity in the hippocampus in vivo (Seckl et al., 
1991), although the mechanisms underpinning this effect are 
obscure. Hippocampal ll/?-HSD is induced by chronic glucocor- 
ticoid excess or stress (Low et al., 1994b). Because chronic glu- 
cocorticoid excess exerts well documented deleterious actions on 
hippocampal cell function and survival (Landfield et al., 1978; 
Sapolsky et al., 1985, 1986; Sapolsky, 1992), it has been postulated 
that such induction of lip-HSD is protective (Monder, 1991; Low 
et al., 1994b; Seckl and Olsson, 1995). Nevertheless, the presence 
of 11/3-HSD activity in the hippocampus contradicts a majority of 
data, which indicate nonselective MRs at this site. 
Recently, it has become apparent that there are at least two 
distinct ll@HSD isoforms (Seckl, 1993). Target organs for aldos- 
terone and the placenta express a high-affinity, NAD’-dependent 
enzyme (ll/%HSD2), which is an exclusive 11/3-dehydrogenase 
(corticosterone inactivating enzyme) (Brown et al., 1993; Albiston 
et al., 1994). In contrast, the liver-derived isoform (ll@HSDl) is 
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a lower-affinity, NADP+/NADPH-dependent enzyme (Lakshmi 
and Monder, 1988; Agarwal et al., 1989). Expression of 
llP-HSDl cDNA in a range of cell lines encodes either a bidirec- 
tional enzyme (Agarwal et al., 1989) or a predominant 
ll@-reductase (Duperrex et al., 1993; Low et al., 1994a). 
ll@Reductase activity, best observed in intact cells, activates 
ll-dehydrocorticosterone to alter target gene transcription and 
differentiated cell function (Duperrex et al., 1993; Low et al., 
1994b). In homogenates of hippocampus, both dehydrogenation 
and reduction occur (Lakshmi et al., 1991), but the reaction 
direction in intact cells is unknown. We therefore have examined 
llfi-HSD activity and its function in primary cultures of fetal 
hippocampal cells. 
MATERIALS AND METHODS 
Cell culture media were obtained from Gibco (Paisley, UK); corticoste- 
rone (B), 11-dehydrocorticosterone (A), poly-n-lysine, insulin, apo-trans- 
ferrin, putrescine, sodium selenite, and progesterone were obtained from 
Sigma (Poole, UK). Tissue culture plastics were from Costar UK Ltd 
(High Wycombe, Bucks, UK). [“HI-1,2,6,7-Corticosterone ([3H]B; - 72 
Ci/mmol) was obtained from Amersham International (Aylesbury, Bucks, 
UK). [3H]11-Dehydrocorticosterone ([sH]A) was prepared by incubating 
[3H]B with human placental extract, a concentrated source of llj3- 
dehydrogenase (llS-HSD2), as described previously (Low et al., 1994a). 
Purity was typically >99%, monitored on HPLC. 
Primaly hippocampal neuronal culture. The cell cultures were prepared 
according to a method derived from Mitchell et al. (1990). The medium 
(pH 7.3) contained DMEM with Glutamax-I (0.086%), 10% fetal bovine 
serum (FBS) or donor horse serum (DHS), 15 mM HEPES, 100 IU/ml 
penicillin, and 100 pg/ml streptomycin and glucose increased to 0.2%. 
Day 18 fetuses were removed by laparatomy, and the hippocampi were 
dissected into HBSS containing 15 mM HEPES, pH 7.4. The cells were 
incubated in trypsin-EDTA for 20 min, washed, and mechanically disso- 
ciated by trituration. Cells were seeded at a density of 0.8-1.0 X 10h 
cells/ml of medium and plated on 35 mm Petri dishes previously coated 
with 0.025 mg/ml poly-D-lysine. The cells were cultured in a water- 
saturated atmosphere at 37”C, 10% CO,, for 3 d in the presence of serum, 
and then changed to defined (serum-free) medium (DMEM-F12 contain- 
ing Glutamax-I, 10 p&ml insulin, 100 &ml transferrin, 60 pM putrescine, 
20 nM sodium selenite, 20 nM progesterone. 100 IU/ml nenicillin. and 100 
&ml streptomycin). The cells w&e maintained in this medium for 5 d 
with one-third of the medium changed every 3 d until experimentation. 
Under these conditions, the cultures contained 60-80% neurons with glia 
forming the remainder, as determined by immunostaining of specimen 
cultures with antisera to glial fibrillary axial protein and neuron-specific 
enolase. 
ll@HSD activity. lip-Reductase and llj3-dehydrogenase activity were 
determined in intact primary hippocampal cells by the addition of 25 nM 
[3H]A or [3H]B to the medium, as described previously (Low et al., 
1994a). Aliquots of the culture medium were removed at intervals over 24 
hr and put into ethyl acetate; the steroids were extracted, dried under N,, 
and suspended in 100 ml of ethanol containing 2.5 mg/ml cold A and B. 
Steroids were separated by thin-layer chromatography (TLC) in chloro- 
form/95% ethanol (92:8), and bands were visualized under ultraviolet 
light and scraped into scintillation vials containing 3 ml of liquid scintil- 
lant (Cocktail T, BDH, Luttetworth, UK). The radioactivity in each 
fraction was determined, and enzyme activity was expressed as the per- 
centage conversion to reaction product (Low et al., 1994a). Blanks, 
“H-labeled steroids incubated in medium on dishes without cells and 
extracted as above, were subtracted. 
ll/$Reductase and 11/3-dehydrogenase activity also were determined 
in homogenates of cultured hippocampal cells, broadly as described 
previously (Moisan et al., 1990; Low et al., 1994a). Cells were washed with 
PBS and homogenized in Buffer C [20 mM tricine, 1.07 mM 
(MgCO,),*Mg(OH),*5H,O, 2.67 mM MgSO,, 0.1 tnM EDTA, 33.3 mM 
DTT, and 0.2 mg/ml coenzyme A] containing 0.1% Triton X-100. Protein 
was measured by Bradford’s method (Bio-Rad protein assay kit, Bio-Rad, 
Hemel Hempstead, UK). Preliminary studies established conditions such 
that the amount of protein added was within the linear portion of the 
relationship between protein concentration and percentage substrate 
conversion. Thus, an aliquot of hippocampal cell homogenate (typically 
64 pg protein/ml) was incubated at 37°C for 60 min with 10 IIM [3H]B 
(lip-dehydrogenase) or [3H]A (lip-reductase), 400 pM NADP+ or 
NADPH. and PBS to a total volume of 50 nl. Steroids were extracted and 
separated by TLC, and enzyme activity’ was calculated. Blanks were 
subtracted. 
ll@HSD mRNA analysis. Expression of llP-HSDl and ll@HSD2 
mRNA was determined by PCR. In brief, total RNA was extracted from 
cell homogenates with guanidinium thiocyanate (Chomczynski and Sac- 
chi, 1987). One microgram of RNA was subjected to reverse transcription 
in a total volume of 20 ~1 using the Promega Reverse transcription kit 
(Promega, Southampton, UK). A 2 ~1 aliquot of the reverse transcription 
reaction was used in the PCR reaction after denaturation at 96°C for 10 
min. The PCR mix contained 1.5 mM MgCI,, 40 pM dNTPs, 20 pmol of 
each primer, and 2.5 U of Taq DNA polymerase in a final volume of 50 
~1. The primer pairs for 11/3-HSDl were 869P (5’~AAAGCTTGTCACQ 
TGGGGCCAGCAAA-3’), corresponding to nucleotides 178-207 of rat 
lIP-HSDl cDNA, and 868P (5’-AGGATCCAGfAAGCAAACT-GCT- 
TGCA-3’), complementary to nucleotides 648-628 of rat ll&HSDl 
cDNA. The primer pairs for llfl-HSD2 were P2520 (5’~CAATGCTG- 
GCCTCAACATGGT-3’). corresoondine to nucleotides 624-644 of the 
rat ll@-HSD2 cDNA, and P25’21 (5’~GGTCCTGGGTTGTGTCAT- 
GAA-3’) complementary to nucleotides 1297-1277 of the rat lip-HSD2 
cDNA sequence (Zhou et al., 1995). Both sets of primers span intron 
sequences to distinguish DNA products (>4 kb for llS-HSDl, -0.93 kb 
fo;llP-HSD2) from mRNA products (0.43 kb for ll$HSDl, 0.63 kb for 
llB-HSD2). The PCR conditions were 30 cvcles of 96°C for 30 sec. 50°C 
for 45 set, and 72°C for 90 set, followed by extension at 72°C for 16 min. 
Modulation of 11/3-HSD activity in primary hippocampal cells. To deter- 
mine whether llfi-HSD activity in intact hippocampal cells was inhibited 
by licorice derivatives, cultures were pretreated with carbenoxolone 
(lo-” M) for 24 hr, and enzyme activity in lip-reductase and 
11/3-dehydrogenase directions was estimated, as above. Glucocorticoid 
effects on enzyme activity were determined by preincubation of cultured 
hippocampal cells with dexamethasone (lo-’ M) for 72 hr before enzyme 
measurement in intact cells after 8 hr incubation with ‘H-labeled steroids 
(a period chosen to reflect submaximal 11/3-reductase and detectable 
lip-dehydrogenase activities). 
Effects of IIP-HSD on hippocampal cell vulnerability to kainate toxicity. 
To determine the functional relevance of 11/3-HSD activity in primary 
cultures of hippocampal cells, the effects of corticosterone and ll-dehy- 
drocorticosterone in the presence or absence of carbenoxolone on cell 
survival in response to kainic acid stimulation were determined, as 
described previously (Sapolsky, 1986; Packan and Sapolsky, 1990). In 
brief, cells were cultured as described above, but in the presence of 2% 
FBS to improve cell survival in the presence of kainic acid. This did not 
alter the predominant llP-reduction in intact hippocampal cells or affect 
enzyme activity levels: corticosteroid levels are <10-i” M in FBS (S.C. 
Low and J. R. Seckl, unpublished observations.) Plates of cells were 
pre-exposed to 11-dehydrocorticosterone (10e5 M) or corticosterone 
(lo-’ M) in the presence or absence of carbenoxolone ( 10m6 M) for 24 hr. 
Controls included cultures exposed to carbenoxolone alone and cultures 
to which nothing was added. All cells then received kainic acid (10m5 M). 
After 48 hr, cells were washed in PBS, scraped into 1.2 ml of potassium 
phosphate buffer, pH 7.5, containing 0.5% Triton X-100, and lactate 
dehydrogenase activity was determined, using a kit (Sigma) according to 
the instructions of the manufacturer, as a measure of cell survival (Sapol- 
sky, 1986; Packan and Sapolsky, 1990). Control plates that were not 
exposed to steroid or carbenoxolone were taken to represent 100% 
survival, and blanks represented 0% survival. 
Statistics. Three to eight plates of cells were used for each data point. 
Data were assessed by ANOVA followed by Newman-Keulspost hoc test 
or Student’s t tests, where appropriate. Significance was set at p < 0.05. 
Values are mean 2 SEM. 
RESULTS 
1 1 /3-HSD in cultured hippocampal cells 
Primary fetal hippocampal cell cultures showed clear 11/3-HSD 
activity in cell homogenates. NADP+-dependent llp-dehydroge- 
nase and NADPH-dependent llP-reductase activity was clearly 
detectable after 1 hr incubation (Fig. 1). NAD+-dependent activ- 
ity was only just above basal enzyme activity (with no added 
cosubstrate; Fig. 1). PCR analysis showed clear expression of 
llfl-HSDl mRNA, but no detectable expression of 11/3-HSD2 
mRNA (Fig. 2). Northern analysis showed only one hybridizing 
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“One NAD NADP none NADPH co-substrate 
11 O-dehydrogenase 11iSreductase direction 
--I lj3HSD2 
-4lPHSDI 
Figure 2. Presence of lip-HSDl mRNA in cultured primary hippocam- 
pal cells. Total RNA from 11-d-old cultures was subjected to reverse 
I * __ 
Figure 1. Cosubstrate dependence and reaction direction of lip-HSD in 0 
4 6 12 16 20 24 
homogenates of cultured primary hippocampal cells. Cosubstrates were time 
added at 400 FM. Note the predominant NADP+/NADPH-dependent Figure 3. 
reaction, typical of llp-HSDl, and the obvious bidirectional activity in 
Reaction direction of llfl-HSD in intact primary hippocampal 
homogenates. *p < 0.05 and ***p < 0.0001 compared with the appropri- 
cells in vitro. [3H]Corticosterone or [3H]11-dehydrocorticosterone was 
ate control without exogenous cosubstrate. 
added to the culture medium, and [3H]corticosteroids in the medium were 
assayed at intervals. Note the predominant lip-reduction in intact hip- 
pocampal cells. Carbenoxolone (CBX, 1O-6 M) inhibits the reaction. *p < 
species of llP-HSDl transcript, identical in size to the transcript 
in rat liver (data not shown), confirming previous studies of 
11/3-HSDl transcripts in adult and fetal rat hippocampus in vivo 
(Moisan et al., 1990, 1992; Low et al., 1994b). 
In contrast, predominant lip-reduction was found (Fig. 3) in 
intact hippocampal cells, with clearly detectable conversion of 
inert ll-dehydrocorticosterone to corticosterone within 30 min of 
addition of steroid, and 78% conversion after 24 hr. This repre- 
sented plateau activity because no further conversion occurred 
after 48 hr incubation with [3H]A (data not shown). 
llfi-Dehydrogenase activity only became detectable after 8 hr 
incubation with [3H]B (4 t 1% conversion) and reached a mere 
6.5 + 1% conversion at 24 hr (Fig. 3). Pretreatment of cultures 
with the llP-HSD inhibitor carbenoxolone (low6 M) almost com- 
pletely inhibited enzyme activity in intact hippocampal cells in 
0.01 for lip-reductase activity compared with either carbenoxolone-inhib- 
ited lip reductase or 11/3-dehydrogenase t the same time point. 
both lip-reductase (Fig. 3) and llP-dehydrogenase (data not 
shown) directions. 
Glucocorticoid modulation of hippocampal cell 
1 l@HSD activity 
Treatment of primary hippocampal cell cultures with dexameth- 
asone (10K7 M) for 72 hr increased l@HSD activity in cell 
homogenates (102% increase in lip-dehydrogenase, 72% in- 
crease in lip-reductase). In intact cells, this was exclusively an 
increase in 11/3-reductase activity (by 43%) with no alteration in 
dehydrogenation detected (Fig. 4). 
Effect of 11 j3-HSD on hippocampal cell survival in the 
presence of kainic acid 
Preliminary experiments showed that both 10V7 and lo-’ M 
corticosterone potentiated kainic acid-mediated neurotoxicity, 
but this was considerably more apparent with the higher dose 
(data not shown). We therefore used the 10V5 M dose to study the 
effect of llP-HSD in these cells. In the presence of corticosterone, 
kainic acid exerted significantly greater neurotoxicity than did 
kainic acid alone (Fig. 5), confirming previous studies (Sapolsky, 
1986; Packan and Sapolsky, 1990). Carbenoxolone (1O-6 M) did 
not alter the effect of corticosterone (lo-’ M) on hippocampal cell 
loss in the presence of corticosterone, nor did 10e6 M carbenox- 
olone alone affect cell loss in the face of kainic acid stimulation 
(Fig. 5). 11-Dehydrocorticosterone (10V5 M) also potentiated 
kainic acid neurotoxicity and was at least as potent in this action 
as corticosterone (Fig. 5). However, inhibition of 11/3-HSD with 
carbenoxolone (10V6 M) abolished the cytotoxic potentiating ef- 
fects of 11-dehydrocorticosterone in hippocampal cultures. 
transcription followed by PCR using primers specific for llfl-HSDl and 
llP-HSD2. Lane 1, Negative control (C); lane 2, positive control kidney 
RNA (K); lane 3, hippocampal cell culture RNA (H); lane 4, negative 
control (C); lane 5, positive control kidney RNA (K); and lane 6, hip- 
pocampal cell culture RNA (17). M indicates marker lanes. Reactions in 
lanes 1, 2, and 3 contained lip-HSDl-specific primers, and lanes 4, 5, and 
6 contained 11/3-HSD2-specific primers. Note the presence of a band in 
lane 3 corresponding to hippocampal llfl-HSDl. The band in Zanes 5 and 
6 migrating at -0.9 kb corresponds to DNA-generated PCR product (see 
Results). 
DISCUSSION 
These studies clearly demonstrate llfl-HSD activity in primary 
hippocampal cell cultures. A majority of the cultured cells were 
neurons, and it seems likely that the activity, taken together with 
previous immunocytochemical and in situ hybridization data 
showing a predominant neuronal localization of ll@HSD in 
several brain regions in vivo (Moisan et al., 1990; Sakai et al., 
1992), reflects lip-HSD largely in neurons in the fetal hippocam- 
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80 
Figure 4. Effect of dexamethasone P 
(10m7 M for 72 hr) on 11/3-HSD activity 
in intact primary hippocampal cells 
$$ 
I 20 
and cell homogenates (inset). Note $ 
that dexamethasone induces hip- T- 
pocampal cell lip-HSD activity in 
vitro, but the reaction is ll@reduction 0 
in intact cells. *p < 0.05 compared 
with control. 
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lzzl dexamethasone 
11 R-reductase 
pal cultures. llP-HSD activity was detectable in culture for more 
than 8 d, suggesting that it is stable under the conditions that were 
used. In intact hippocampal cells, lip-reduction was clearly the 
predominant reaction direction. Dehydrogenation was barely de- 
tectable in intact hippocampal cells, and at the 8 hr time point at 
which 11/3-dehydrogenation became detectable and llp-reduc- 
tion had not reached plateau values, the ratio of reduction to 
dehydrogenation was 11S:l. Few previous studies have addressed 
the reaction direction of 11/3-HSD in brain in viva. Those reported 
have used peripheral injection of radiolabeled glucocorticoids and 
have examined the concentrations of 11-hydroxy to ll-keto prod- 
ucts in target tissues (Burton and Tufnell, 1967). Uptake into the 
brain is low using such approaches, and in any event the data are 
complicated by peripheral conversion of steroids before entry into 
the brain, which largely reflects the balance of 11/3-reduction in 
the liver and 11/3-dehydrogenation in the kidney. No studies have 
examined 11/3-reduction in brain in vivo, and indeed it is difficult 
to envisage satisfactory experimental protocols to overcome pe- 
ripheral interconversion of corticoids without their direct infusion 
into the central nervous system. 
In contrast, in homogenates of hippocampal cells, llp-dehy- 
drogenase was readily detectable and indeed exceeded 11/3-reduc- 
tase activity. This confirms studies in homogenates of hippocam- 
pus in vivo, which show both dehydrogenation and reduction 
reactions (Lakshmi et al., 1991; Seckl et al., 1993). The basis for 
the discrepancy between predominant reduction in intact cells and 
dehydrogenation in homogenates of these cells is unclear but not 
unique to the hippocampus. Thus, transfection of COS7 cells with 
an expression plasmid encoding 11/3-HSDl produces exclusively 
ll@-reductase activity in intact cells, but potent dehydrogenation 
is revealed when the transfected cells are homogenized (Low et 
al., 1994a). Reaction direction has been suggested to be deter- 
mined by the glycosylation status of the enzyme or the tissue 
cosubstrate condition (Agarwal et al., 1990; Monder and White, 
1993). Variations in glycosylation cannot explain near-exclusive 
reduction in intact hippocampal cells when dehydrogenation pre- 
dominates immediately after these cells are homogenized. More- 
over, any variations in NADP+/NADPH ratios are unlikely to be 
sufficient to account for the dramatic change in reaction direction 
observed, and even gross changes in these ratios in intact cells 
11 R-dehydrogenase 
*E‘T 
.g .8 20 
;g 
$8 10 
z?i 
0 
dehydrogenase reductase 
control 
have little effect on reaction direction of 11/3-HSDl, at least in the 
liver (Jamieson et al., 1995). Thus, it seems more likely that the 
subcellular context of the enzyme determines the reaction direc- 
tion, with homogenization disrupting this. Whether or not the 
reductase component is unstable in homogenates, it is clear from 
these data that dehydrogenation is revealed by cellular disruption, 
but it is at most a minor reaction in intact hippocampal cells and, 
by implication, in the hippocampus in vivo. The lack of 
11/3-dehydrogenation i  intact hippocampal cell cultures also con- 
curs with the nonselectivity of hippocampal MRs in vivo (de Kloet 
et al., 19751991; Reul and de Kloet, 1985; McEwen et al., 1986a). 
Whether 11/3-HSD2 (an exclusive dehydrogenase) is present in 
the hippocampus is still debatable. Northern analysis shows no 
expression of lip-HSD2 mRNA in whole (human) brain 
I * 
” control A A+CBX B B+CBX CBX 
Figure 5. Effect of pretreatment with corticosterone (B; 10m5 M) and 
ll-dehydrocorticosterone (A; lo-” M) with or without carbenoxolone 
(CBX, 1Om6 M) on hippocampal cell loss after exposure to kainic acid 
(10W5 M). Carbenoxolone alone has no effect on cells and does not alter 
the neurotoxic potentiation of corticosterone (B YS B+CBX). However, 
11-dehydrocorticosterone (A) toxicity is prevented by carbenoxolone (A vs 
A+CBX), indicating that hippocampal cell lip-HSD acts as a functional 
11/3-reductase in this model. *p < 0.05 compared with control; ‘p < 0.05 
compared with A alone. 
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(Albiston et al., 1994), and in situ hybridization studies have failed 
to find ll@HSD2 mRNA in the adult rat hippocampus (Roland 
et al., 1995). In contrast, a recent PCR-based study showed 
lip-HSD2 transcripts in adult hippocampus (Zhou et al., 1995). 
Using a similar PCR approach, however, we could not detect 
lip-HSD2 mRNA in primary hippocampal cell cultures and, 
importantly, found little NAD+-dependent bioactivity. Thus, hip- 
pocampal expression of this MR-protective 11/3-HSD isoform is 
probably negligible, at least in adult and late fetal life. 
Previous studies have shown that chronic glucocorticoid (dexa- 
methasone) excess or stress increase 11/3-HSDl mRNA expres- 
sion and enzyme bioactivity (measured as dehydrogenation in 
homogenates) in the rat hippocampus (Low et al., 1994b). Be- 
cause treatment of primary hippocampal cultures with dexameth- 
asone increased lip-HSD activity, it is probable that this effect of 
glucocorticoids is mediated directly on hippocampal neurons, and 
there is a putative glucocorticoid response element in the pro- 
moter of the rat llfl-HSDl gene (Moisan et al., 1992). Moreover, 
preliminary data from transfection experiments with plasmids in 
which lip-HSDl promoter DNA is fused to a reporter gene 
suggest that a functional glucocorticoid response element lies 
within 3700 base pairs of the transcription start site (K. E. Chap- 
man, M. Voice, R. Wallace, V. Lyons, and J. R. Seckl, unpub- 
lished observations). Although it has been proposed that induc- 
tion of lip-HSD in the hippocampus may protect vulnerable 
neurons from the deleterious consequences of chronic glucocor- 
ticoid excess (Monder, 1991; Low et al., 1994b), the activity 
induced by dexamethasone was exclusively 11/3-reductase, a find- 
ing incompatible with this notion. Thus, hippocampal ll@HSD 
may potentiate rather than attenuate the neurotoxic effects of 
chronic glucocorticoid overexposure. 
To examine this further, the effects of enzyme inhibition in both 
reductase and dehydrogenase directions was determined by using 
carbenoxolone. Potentiation of kainic acid neurotoxicity with lo-’ 
and lo-’ M corticosterone was found in primary hippocampal cell 
cultures, confirming previous studies (Sapolsky, 1986; Packan and 
Sapolsky, 1990). Although supraphysiological levels of steroids 
were used in vitro, physiological concentrations (lo-’ M) are 
effective in potentiating kainic acid neurotoxicity in this system 
(Packan and Sapolsky, 1990; and these data), although the 
changes were small during the short time course used here. In 
viva, corticosteroid effects take many days to become manifest 
(Sapolsky et al., 198.5), and we have used higher concentrations to 
amplify effects in cell cultures. That the effect of corticosterone 
was unaltered by carbenoxolone in a dose that inhibited both 
reaction directions but had no direct effect on cell survival sup- 
ports the relative lack of importance of lip-dehydrogenation in 
these cells. ll-Dehydrocorticosterone, which has 104-fold lower 
affinity for receptors than does corticosterone (Ulmann et al., 
1975; Armanini et al., 1983), was at least as effective as corticos- 
terone in potentiating kainic acid toxicity. The functionality of 
11/3-reductase was clear, inasmuch as 11-dehydrocorticosterone 
was ineffective when llP-HSD was inhibited by carbenoxolone. 
These data support the predominant lip-reductase action of 
hippocampal llfl-HSD. 
The reasons for an enzyme regenerating active glucocorticoids 
in the hippocampus are obscure. Hippocampal cells are exquis- 
itely sensitive to glucocorticoid concentrations, with granular neu- 
ronal dysfunction and possibly death in the dentate gyrus after 
adrenalectomy (Sloviter et al., 1989; Gould et al., 1990) and 
pyramidal neuronal loss in the cornu ammonis with glucocorticoid 
excess (Landfield et al., 1978; Sapolsky et al., 1985, 1986; 
Sapolsky, 1985, 1992; Landfield and Eldridge, 1991). In the rat, 
corticosterone levels are very low during the day but show a 
pronounced diurnal increase in the evening. The biological im- 
portance of this rhythm is unclear, but the maintenance of many 
constitutive cellular functions may require more than the minimal 
levels of circulating corticosterone that pertain during the major- 
ity of the day. Thus, local lip-reduction may increase corticoster- 
one levels in specific tissues and, hence, 1 l-dehydrocorticosterone 
may form a circulating reservoir of inert corticosteroid for cell- 
specific activation (the apparent absence of ll@HSD2 in the 
hippocampus suggests that 11-dehydrocorticosterone comes from 
the periphery rather than from local cellular production). Cer- 
tainly in humans, cortisone (the equivalent of ll-dehydrocorti- 
costerone) shows near-constant levels throughout the 24 hr pe- 
riod. Moreover, plasma concentrations of cortisone (which circu- 
lates largely unbound at -100 nmol/l) approximate or even ex- 
ceed “free” cortisol levels, providing plentiful substrate for 11/3- 
reductase (Walker et al., 1992). Similarly, levels of ll- 
dehydrocorticosterone at -50 nmol/l are found in rat plasma (R. 
Best and J. R. Seckl, unpublished observations), concentrations 
well in excess of “free” corticosterone levels during the diurnal 
nadir. Such cell-specific activation of an inert circulating form is 
not unique to glucocorticoids and may be analogous to the acti- 
vation of thyroxine to tri-iodothyronine by 5’-monodeiodinase 
and testosterone to dihydrotestosterone by Sa-reductase in other 
tissues. 
Why the activity of hippocampal 1 lp-reductase should increase 
with chronically elevated glucocorticoids also is unclear, because 
this seems to increase the neuron-jeopardizing effects of glucocor- 
ticoid excess. Perhaps the short- and medium-term metabolic and 
functional benefits of maximizing glucocorticoid exposure during 
stress outweigh any long-term detriments, particularly because 
potent negative feedback effects would be expected to rapidly 
attenuate glucocorticoid levels under most physiological circum- 
stances. Further determination of the importance of hippocampal 
11/3-HSD activity will be assisted by the development of selective 
Ilo-reductase inhibitors or transgenic animals lacking 11/3-HSDl. 
Nevertheless, it is intriguing to speculate that measures to atten- 
uate hippocampal lip-reductase may reduce neuronal vulnerabil- 
ity to glucocorticoid toxicity in a target-specific manner, analogous 
to the effects of long-term maintenance of more generalized low 
glucocorticoid levels by adrenalectomy (Landfield et al., 1978) 
or increasing sensitivity to glucocorticoid negative feedback 
(Sapolsky et al., 1984; Meaney et al., 1988, 1993; Seckl and Olsson, 
1995). 
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